DAVID POPLACK to Humans
This is a "connection" page, showing publications DAVID POPLACK has written about Humans.
Connection Strength
0.360
-
Addressing the childhood cancer crisis in sub-Saharan Africa. Lancet Oncol. 2023 07; 24(7):729-732.
Score: 0.024
-
Improving Childhood Cancer Survivor Care Through Web-Based Platforms. Oncology (Williston Park). 2018 01 15; 32(1):e1-e10.
Score: 0.016
-
Childhood cancer survivor care: development of the Passport for Care. Nat Rev Clin Oncol. 2014 12; 11(12):740-50.
Score: 0.013
-
Reply to "childhood cancer in Africa". Pediatr Blood Cancer. 2014 Aug; 61(8):1524.
Score: 0.012
-
Management strategies in acute lymphoblastic leukemia. Oncology (Williston Park). 2011 Apr 15; 25(4):328-35.
Score: 0.010
-
Introduction: pediatric oncology. Cancer J. 2005 Jul-Aug; 11(4):253-4.
Score: 0.007
-
Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63.
Score: 0.007
-
Clinician perceptions of Passport for Care, a web-based clinical decision support tool for survivorship care plan delivery. Pediatr Blood Cancer. 2023 01; 70(1):e30070.
Score: 0.006
-
Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol. 2000 Aug; 17(3):151-62.
Score: 0.005
-
Capacity building: a novel pediatric hematology-oncology fellowship program in sub-Saharan Africa. Blood Adv. 2018 11 30; 2(Suppl 1):11-13.
Score: 0.004
-
New cytotoxic drugs for intrathecal administration. J Neurooncol. 1998 Jun-Jul; 38(2-3):219-23.
Score: 0.004
-
An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110.
Score: 0.004
-
Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl. 1998; 11:48-51.
Score: 0.004
-
Central nervous system leukemia. Curr Opin Oncol. 1996 Jan; 8(1):13-9.
Score: 0.004
-
Pharmacologic strategies for the treatment of meningeal malignancy. Invest New Drugs. 1996; 14(1):69-85.
Score: 0.004
-
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Cancer Res. 1995 Sep 15; 55(18):4069-72.
Score: 0.003
-
Advances in the treatment of meningeal cancers. Crit Rev Oncol Hematol. 1995 Aug; 20(1-2):87-98.
Score: 0.003
-
Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations. Leukemia. 1994 Jun; 8(6):963-7.
Score: 0.003
-
Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells. Biochem Pharmacol. 1993 Nov 02; 46(9):1627-36.
Score: 0.003
-
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor. J Clin Oncol. 1993 Sep; 11(9):1795-803.
Score: 0.003
-
Variability in the oral bioavailability of all-trans-retinoic acid. J Natl Cancer Inst. 1993 Jun 16; 85(12):993-6.
Score: 0.003
-
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts. Biochem Pharmacol. 1993 Apr 06; 45(7):1493-501.
Score: 0.003
-
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res. 1993 Mar 01; 53(5):1032-6.
Score: 0.003
-
Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. Cancer Res. 1992 Jun 15; 52(12):3503-5.
Score: 0.003
-
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res. 1992 Feb 01; 52(3):521-4.
Score: 0.003
-
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia. Cancer Chemother Pharmacol. 1992; 30(2):155-7.
Score: 0.003
-
Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T-cell receptor gene patterns. Leukemia. 1991 Dec; 5(12):1015-25.
Score: 0.003
-
Perspective on...the new PSA screening recommendations. Oncology (Williston Park). 2011 Nov 15; 25(12):1183, 1187-8, 1190.
Score: 0.003
-
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res. 1991 Nov 15; 51(22):6079-83.
Score: 0.003
-
Antiretroviral drug development and clinical pharmacology. Pediatr Infect Dis J. 1991 Nov; 10(11):849-57.
Score: 0.003
-
Current pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16.
Score: 0.003
-
Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park). 1991 May; 5(5):107-16; discussion 123, 127.
Score: 0.003
-
Development of chemotherapy treatment for pediatric brain tumors. Neurol Clin. 1991 May; 9(2):363-73.
Score: 0.003
-
The child with recurrent solid tumor. Pediatr Clin North Am. 1991 Apr; 38(2):489-504.
Score: 0.003
-
Complications of leukemia. Pediatr Rev. 1991 Apr; 12(10):313-8.
Score: 0.003
-
Increasing diversity in pediatric hematology/oncology. Pediatr Blood Cancer. 2011 Jul 15; 57(1):147-52.
Score: 0.003
-
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule. Cancer Res. 1990 Aug 01; 50(15):4464-7.
Score: 0.002
-
Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas. Invest New Drugs. 1990 May; 8(2):181-2.
Score: 0.002
-
Leadership: "They never taught me this in medical school". J Pediatr Hematol Oncol. 2010 May; 32(4):304-8.
Score: 0.002
-
Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits. Am J Pediatr Hematol Oncol. 1990; 12(2):174-81.
Score: 0.002
-
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors. Cancer Chemother Pharmacol. 1990; 26(5):343-4.
Score: 0.002
-
Phase I trial and pharmacokinetic evaluation of fazarabine in children. Cancer Res. 1989 Sep 15; 49(18):5213-6.
Score: 0.002
-
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. J Pediatr. 1989 May; 114(5):880-4.
Score: 0.002
-
The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann Intern Med. 1989 Feb 15; 110(4):279-85.
Score: 0.002
-
Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol. 1989; 11(1):74-86.
Score: 0.002
-
Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy? Am J Pediatr Hematol Oncol. 1989; 11(3):324-6.
Score: 0.002
-
Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol. 1988 Dec; 6(12):1882-6.
Score: 0.002
-
Late CNS sequelae in long term survivors of childhood leukemia. An Esp Pediatr. 1988 Oct; 29 Suppl 34:19-26.
Score: 0.002
-
Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am. 1988 Aug; 35(4):903-32.
Score: 0.002
-
Altered phenytoin clearance during intensive chemotherapy for acute lymphoblastic leukemia. J Pediatr. 1988 Jun; 112(6):996-9.
Score: 0.002
-
Bioavailability of low-dose vs high-dose 6-mercaptopurine. Clin Pharmacol Ther. 1988 May; 43(5):588-91.
Score: 0.002
-
Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid. J Pharmacol Exp Ther. 1988 May; 245(2):466-70.
Score: 0.002
-
A pediatric phase I and pharmacokinetic study of spirohydantoin mustard. Cancer Res. 1988 Apr 15; 48(8):2292-5.
Score: 0.002
-
Stability of 5-fluorouracil in whole blood and plasma. Clin Chem. 1987 Dec; 33(12):2299-300.
Score: 0.002
-
Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatric cancer patients and rhesus monkeys. Pain. 1987 Sep; 30(3):339-348.
Score: 0.002
-
The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther. 1987 Apr; 41(4):384-7.
Score: 0.002
-
Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987 Feb; 5(2):202-7.
Score: 0.002
-
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504.
Score: 0.002
-
Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res. 1986 Dec; 46(12 Pt 1):6101-4.
Score: 0.002
-
Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine. Cancer Res. 1986 Dec; 46(12 Pt 1):6286-9.
Score: 0.002
-
Adverse prognostic influence of hepatitis B virus infection in acute lymphoblastic leukemia. Cancer. 1986 Sep 01; 58(5):1096-100.
Score: 0.002
-
The pharmacology of orally administered chemotherapy. A reappraisal. Cancer. 1986 Jul 15; 58(2 Suppl):473-80.
Score: 0.002
-
Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia. Cancer Res. 1986 Mar; 46(3):1495-8.
Score: 0.002
-
Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines. Cancer Res. 1985 Sep; 45(9):4156-61.
Score: 0.002
-
Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia. J Clin Oncol. 1985 Sep; 3(9):1227-31.
Score: 0.002
-
Intracranial and otological presentation of acute lymphocytic leukemia. Neurosurgery. 1985 Aug; 17(2):309-12.
Score: 0.002
-
Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am. 1985 Jun; 32(3):669-97.
Score: 0.002
-
Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol. 1985 Jun; 12(2):131-48.
Score: 0.002
-
Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastoma. Am J Clin Oncol. 1985 Jun; 8(3):210-4.
Score: 0.002
-
Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. J Pediatr. 1985 May; 106(5):723-8.
Score: 0.002
-
Remission induction of meningeal leukemia with high-dose intravenous methotrexate. J Clin Oncol. 1985 Apr; 3(4):485-9.
Score: 0.002
-
Ascending myelopathy after chemotherapy for central nervous system acute lymphoblastic leukemia: correlation with cerebrospinal fluid myelin basic protein. Med Pediatr Oncol. 1985; 13(1):4-8.
Score: 0.002
-
Abnormal computed tomography brain scans in children with acute lymphoblastic leukemia: serial long-term follow-up. J Clin Oncol. 1985 Jan; 3(1):12-8.
Score: 0.002
-
Identification of 6-mercaptopurine riboside in patients receiving 6-mercaptopurine as a prolonged intravenous infusion. Biochem Pharmacol. 1984 Dec 15; 33(24):4089-92.
Score: 0.002
-
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004 Oct 20; 96(20):1557-9.
Score: 0.002
-
Acute megakaryoblastic leukemia in childhood. Cancer. 1984 Oct 01; 54(7):1423-8.
Score: 0.002
-
Massive intrathecal overdose: "check the label twice!". N Engl J Med. 1984 Aug 09; 311(6):400-2.
Score: 0.002
-
Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther. 1984 Jun; 35(6):826-30.
Score: 0.002
-
Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. Cancer Res. 1984 Apr; 44(4):1698-701.
Score: 0.002
-
Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr. 1984 Feb; 104(2):182-6.
Score: 0.002
-
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther. 1983 Dec; 34(6):810-7.
Score: 0.002
-
Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies. J Natl Cancer Inst. 1983 Jul; 71(1):11-7.
Score: 0.001
-
Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med. 1983 Apr 28; 308(17):1005-9.
Score: 0.001
-
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003 Jan 01; 21(1):143-7.
Score: 0.001
-
Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma. Br J Haematol. 1982 Sep; 52(1):97-104.
Score: 0.001
-
Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin. Cancer Res. 1982 Sep; 42(9):3884-6.
Score: 0.001
-
A rapid, single step technique for determination of B and T cell surface markers in malignant lymphoid cells. Exp Hematol. 1982 Sep; 10(8):668-74.
Score: 0.001
-
Lactate dehydrogenase isoenzymes in normal and malignant human lymphoid cells. Blood. 1982 Aug; 60(2):491-4.
Score: 0.001
-
Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys. J Natl Cancer Inst. 1982 Mar; 68(3):391-3.
Score: 0.001
-
Relationship of 5'-nucleotidase activity and antileukemic effect in 2'-deoxycoformycin therapy. Cancer Treat Rep. 1982 Feb; 66(2):387-90.
Score: 0.001
-
Purine pathway enzyme abnormalities in acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 2):4821-23.
Score: 0.001
-
L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res. 1981 Nov; 41(11 Pt 1):4554-8.
Score: 0.001
-
Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 1):4508-11.
Score: 0.001
-
Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. Cancer Res. 1981 Sep; 41(9 Pt 1):3343-6.
Score: 0.001
-
Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia. Blood. 1981 Aug; 58(2):330-2.
Score: 0.001
-
The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med. 1981 Jul; 71(1):47-52.
Score: 0.001
-
Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. Cancer Treat Rep. 1981; 65 Suppl 4:93-6.
Score: 0.001
-
Pregnancy outcome following cancer chemotherapy. Am J Med. 1980 Dec; 69(6):828-32.
Score: 0.001
-
Current concepts. Biochemical markers in lymphoid malignancy. N Engl J Med. 1980 Oct 16; 303(16):918-22.
Score: 0.001
-
Purine nucleoside phosphorylase activity in acute lymphoblastic leukemia. Blood. 1980 Sep; 56(3):380-2.
Score: 0.001
-
Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med. 1980 Jul 03; 303(1):19-21.
Score: 0.001
-
Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia. Cancer. 1980 Jun 15; 45(12):3090-4.
Score: 0.001
-
The detection of Fc-IgA receptors on T and non-T, non-B acute leukemic lymphoblasts. Cell Immunol. 1980 Jun; 52(1):218-22.
Score: 0.001
-
Delayed allergic reactions following intramuscular L-asparaginase. Med Pediatr Oncol. 1980; 8(2):123-5.
Score: 0.001
-
Retinoblastoma treatment. Science. 1999 Jul 30; 285(5428):663-4.
Score: 0.001
-
Characterization of lymphoblast Fc receptor expression in acute lymphoblastic leukemia. Blood. 1979 Jul; 54(1):285-91.
Score: 0.001
-
Diminished lymphoblast 5'-nucleotidase activity in acute lymphoblastic leukemia with T-cell characteristics. N Engl J Med. 1979 Jun 14; 300(24):1374-7.
Score: 0.001
-
Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979 Mar 24; 1(8117):630-3.
Score: 0.001
-
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer. 1999 Jan 15; 85(2):511-6.
Score: 0.001
-
Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol. 1979; 1(2):141-9.
Score: 0.001
-
Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir. Med Pediatr Oncol. 1979; 6(3):207-13.
Score: 0.001
-
Hypothalamic-pituitary dysfunction following CNS prophylaxis in acute lymphocytic leukemia: correlation with CT scan abnormalities. Med Pediatr Oncol. 1979; 7(2):141-51.
Score: 0.001
-
Methotrexate-induced oral mucositis and salivary methotrexate concentrations. Cancer Chemother Pharmacol. 1979; 2(3):225-6.
Score: 0.001
-
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood. 1998 Nov 15; 92(10):3569-77.
Score: 0.001
-
Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. Blood. 1978 Nov; 52(5):1033-6.
Score: 0.001
-
Leukemic relapse 5 1/2 years after allogeneic bone marrow transplantation. Blood. 1978 Aug; 52(2):281-4.
Score: 0.001
-
Acute encephalopathy after initiation of cranial irradiation for meningeal leukaemia. Lancet. 1978 Jul 01; 2(8079):13-5.
Score: 0.001
-
The Ommaya reservoir: newly recognized complications and recommendations for insertion and use. Cancer. 1978 Jun; 41(6):2431-7.
Score: 0.001
-
Detection of double minute chromosomes in a child with acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1998 Mar; 101(2):138-42.
Score: 0.001
-
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60.
Score: 0.001
-
Characteristics of long-term survivors in AML. Med Pediatr Oncol. 1978; 5(1):219-23.
Score: 0.001
-
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. J Clin Oncol. 1998 Jan; 16(1):181-6.
Score: 0.001
-
A primate model for study of methotrexate pharmacokinetics in the central nervous system. Cancer Res. 1977 Jul; 37(7 Pt 1):1982-5.
Score: 0.001
-
A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. Clin Cancer Res. 1997 May; 3(5):713-7.
Score: 0.001
-
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43.
Score: 0.001
-
Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood. 1976 Dec; 48(6):809-16.
Score: 0.001
-
Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer. 1996 Aug 01; 78(3):527-31.
Score: 0.001
-
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. J Clin Oncol. 1996 Mar; 14(3):774-82.
Score: 0.001
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.001
-
A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study. Invest New Drugs. 1996; 13(4):337-42.
Score: 0.001
-
Candida arthritis treated with amphotericin B. J Pediatr. 1975 Dec; 87(6 Pt 1):989-90.
Score: 0.001
-
Clonal expansion of germline B-lineage acute lymphoblastic leukemia in severe combined immunodeficient mice. Oncogene. 1995 Nov 02; 11(9):1753-9.
Score: 0.001
-
Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma. Med Pediatr Oncol. 1995 Jun; 24(6):362-7.
Score: 0.001
-
Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J Clin Oncol. 1995 May; 13(5):1238-41.
Score: 0.001
-
Characterization of cross-resistance to methotrexate in a human breast cancer cell line selected for resistance to melphalan. Biochem Pharmacol. 1995 Apr 18; 49(8):1069-78.
Score: 0.001
-
Lipid peroxidation in the killing of phagocytized pneumococci. Infect Immun. 1974 Dec; 10(6):1321-8.
Score: 0.001
-
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leuk Res. 1994 Nov; 18(11):805-10.
Score: 0.001
-
Bacteriological isolation garment. Lancet. 1974 Jun 22; 1(7869):1261-2.
Score: 0.001
-
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion. J Natl Cancer Inst. 1994 Jan 19; 86(2):143-5.
Score: 0.001
-
Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis. 1993 Dec; 168(6):1380-6.
Score: 0.001
-
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor. Cancer Res. 1993 Jun 01; 53(11):2587-90.
Score: 0.001
-
Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. J Immunother (1991). 1992 Feb; 11(2):111-8.
Score: 0.001
-
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 1992 Feb; 89(2):640-7.
Score: 0.001
-
Phase I/pharmacokinetic reevaluation of thioTEPA. Cancer Res. 1991 Jun 15; 51(12):3171-6.
Score: 0.001
-
Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. Acta Endocrinol (Copenh). 1991 Apr; 124(4):375-80.
Score: 0.001
-
Immunophenotypic analysis of acute lymphoblastic leukemia using routinely processed bone marrow specimens. Arch Pathol Lab Med. 1991 Apr; 115(4):338-42.
Score: 0.001
-
Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr. 1990 Dec; 117(6):980-5.
Score: 0.001
-
Pharmacokinetics of mercaptopurine in children with acute lymphocytic leukemia. N Engl J Med. 1990 Nov 29; 323(22):1565-6.
Score: 0.001
-
High-performance liquid chromatographic method for the analysis of 2',3'-dideoxycytidine in human plasma. J Chromatogr. 1990 Nov 16; 532(2):442-4.
Score: 0.001
-
Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. Cancer Res. 1990 Nov 15; 50(22):7226-31.
Score: 0.001
-
Pharmacology and drug resistance in childhood lymphoblastic leukemia. Hematol Oncol Clin North Am. 1990 Oct; 4(5):871-94.
Score: 0.001
-
High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids. J Chromatogr. 1990 Mar 16; 526(1):69-75.
Score: 0.001
-
Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. J Clin Oncol. 1990 Mar; 8(3):431-42.
Score: 0.001
-
[Infectious complications from intraventricular route of administration in cancer patients]. Probl Med Wieku Rozwoj. 1990; 16:45-53.
Score: 0.001
-
Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood. 1989 Sep; 74(4):1388-95.
Score: 0.001
-
Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies. Blood. 1989 May 15; 73(7):1968-72.
Score: 0.001
-
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989 Mar 15; 49(6):1422-8.
Score: 0.001
-
Human T-cell antigen receptor (TCR) delta-chain locus and elements responsible for its deletion are within the TCR alpha-chain locus. Proc Natl Acad Sci U S A. 1988 Dec; 85(24):9694-8.
Score: 0.001
-
Stimulation of the beta-subunit of the IL-2 receptor induces MHC-unrestricted cytotoxicity in T acute lymphoblastic leukemia cells and normal thymocytes. J Immunol. 1988 Aug 15; 141(4):1202-5.
Score: 0.001
-
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1988 Mar; 32(3):324-6.
Score: 0.001
-
The beta subunit of the interleukin-2 receptor mediates interleukin-2 induction of anti-CD3 redirected cytotoxic capability in large granular lymphocytes. Blood. 1988 Mar; 71(3):825-8.
Score: 0.001
-
T cell receptor alpha-, beta-, and gamma-genes in T cell and pre-B cell acute lymphoblastic leukemia. J Clin Invest. 1987 Aug; 80(2):545-56.
Score: 0.000
-
Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol. 1987 May; 5(5):735-41.
Score: 0.000
-
Infectious complications of intraventricular reservoirs in cancer patients. Pediatr Infect Dis J. 1987 Feb; 6(2):182-9.
Score: 0.000
-
Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987 Jan; 84(1):265-9.
Score: 0.000
-
Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood. NCI Monogr. 1987; (5):207-12.
Score: 0.000
-
Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1986; 3(4):319-24.
Score: 0.000
-
Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol. 1986; 14(3):191-4.
Score: 0.000
-
Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse. J Clin Oncol. 1985 Jan; 3(1):19-24.
Score: 0.000
-
Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL). J Clin Neuropsychol. 1984 Aug; 6(3):325-36.
Score: 0.000
-
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest. 1983 Feb; 71(2):301-13.
Score: 0.000
-
Inhibition of human lymphoproliferation by intravenous lipid emulsion. Clin Immunol Immunopathol. 1982 Nov; 25(2):196-202.
Score: 0.000
-
Phase II study of 5-azacytidine in sarcomas of bone. Am J Clin Oncol. 1982 Aug; 5(4):411-5.
Score: 0.000
-
Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A. 1981 Nov; 78(11):7096-100.
Score: 0.000
-
Activation of leukemic pro-suppressor cells to become suppressor-effector cells. Influence of cooperating normal T cells. N Engl J Med. 1981 Jun 04; 304(23):1382-7.
Score: 0.000
-
Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med. 1981 May 07; 304(19):1121-4.
Score: 0.000
-
Hypothalamic-adenohypophyseal function in male rhesus monkeys. A primate model. J Med Primatol. 1981; 10(2-3):61-71.
Score: 0.000
-
Chronic myelomonocytic leukemia in childhood. Am J Hematol. 1981; 10(2):181-94.
Score: 0.000
-
Fc receptors on human T lymphocytes. V: Effects of colchicine and cytochalasin B on Fc receptor expression. J Immunol. 1980 Nov; 125(5):2215-9.
Score: 0.000
-
Active transport of methotrexate from cerebrospinal fluid in humans. Cancer Res. 1980 Jul; 40(7):2184-7.
Score: 0.000
-
Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med. 1980 Apr; 68(4):486-91.
Score: 0.000
-
The mononuclear phagocyte system: role in expression of immunocompetence in neonatal and adult life. Pediatrics. 1979 Nov; 64(5 Pt 2 Suppl):829-33.
Score: 0.000
-
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug; 67(2):194-200.
Score: 0.000
-
ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity. Clin Exp Immunol. 1979 Mar; 35(3):447-53.
Score: 0.000
-
Neurotoxicities of current leukemia therapy. Am J Pediatr Hematol Oncol. 1979; 1(2):127-40.
Score: 0.000
-
Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep. 1978 Dec; 62(12):2031-4.
Score: 0.000
-
Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest. 1978 Sep; 62(3):710-2.
Score: 0.000
-
Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent trauma. J Pediatr. 1978 May; 92(5):849-50.
Score: 0.000
-
"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood. 1978 May; 51(5):835-42.
Score: 0.000
-
Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med. 1978 Apr 13; 298(15):815-8.
Score: 0.000
-
Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet. 1978 Mar 18; 1(8064):581-3.
Score: 0.000
-
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer. 1978 Mar; 41(3):1059-63.
Score: 0.000
-
Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma. Cancer Treat Rep. 1978 Feb; 62(2):247-50.
Score: 0.000
-
Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. N Engl J Med. 1978 Jan 12; 298(2):66-72.
Score: 0.000
-
Meningeal relapse of orbital rhabdomyosarcoma. Med Pediatr Oncol. 1978; 4(3):247-51.
Score: 0.000
-
Leukoencephalopathy following chemotherapy for rhabdomyosarcoma: reversibility of cerebral changes demonstrated by computed tomography. J Pediatr. 1977 Jul; 91(1):77-9.
Score: 0.000
-
Computer assisted tomography in methotrexate encephalopathy. J Comput Assist Tomogr. 1977 Apr; 1(2):216-21.
Score: 0.000
-
Blindness during remission in two patients with acute lymphoblastic leukemia: a possible complication of multimodality therapy. Cancer. 1977 Jan; 39(1):58-61.
Score: 0.000
-
Hepatitis B virus infection in the Wiskott-Aldrich syndrome. J Pediatr. 1976 Apr; 88(4 Pt 1):561-4.
Score: 0.000
-
Reversible dementia temporally associated with intraventricular therapy with methotrexate in a child with acute myelogenous leukemia. J Pediatr. 1976 Jan; 88(1):131-3.
Score: 0.000
-
A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia. Cancer Res. 1975 Dec; 35(12):3715-20.
Score: 0.000
-
Prolonged granulocytopenia from incompatible platelet transfusions. N Engl J Med. 1974 May 30; 290(22):1220-3.
Score: 0.000